Literature DB >> 14563970

Topography and temporal evolution of hypoxic viable tissue identified by 18F-fluoromisonidazole positron emission tomography in humans after ischemic stroke.

R Markus1, D C Reutens, S Kazui, S Read, P Wright, B R Chambers, J I Sachinidis, H J Tochon-Danguy, G A Donnan.   

Abstract

BACKGROUND AND
PURPOSE: We sought to characterize the spatial and temporal evolution of human cerebral infarction. Using a novel method of quantitatively mapping the distribution of hypoxic viable tissue identified by 18F-fluoromisonidazole (18F-FMISO) PET relative to the final infarct, we determined its evolution and spatial topography in human stroke.
METHODS: Patients with acute middle cerebral artery territory stroke were imaged with 18F-FMISO PET (n=19; <6 hours, 4; 6 to 16 hours, 4; 16 to 24 hours, 5; 24 to 48 hours, 6). The hypoxic volume (HV) comprised voxels with significant (P<0.05; >1 mL) uptake on statistical parametric mapping compared with 15 age-matched controls. Central, peripheral, and external zones of the corresponding infarct on the anatomically coregistered delayed CT were defined according to voxel distance from the infarct center and subdivided into 24 regions by coronal, sagittal, and axial planes. Maps ("penumbragrams") displaying the percentage of HV in each region were generated for each time epoch.
RESULTS: Higher HV was observed in the central region of the infarct in patients studied within 6 hours of onset (analysis of covariance [ANCOVA]; P<0.05) compared with those studied later, in whom the HV was mainly in the periphery or external to the infarct. HV was maximal in the superior, mesial, and posterior regions of the infarct (ANCOVA; P<0.05).
CONCLUSIONS: These observations suggest that infarct expansion occurs at the expense of hypoxic tissue from the center to the periphery of the ischemic region in humans, similar to that seen in experimental animal models. These findings have important pathophysiological and therapeutic implications.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14563970     DOI: 10.1161/01.STR.0000094422.74023.FF

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  28 in total

1.  Feasibility of 62Cu-ATSM PET for evaluation of brain ischaemia and misery perfusion in patients with cerebrovascular disease.

Authors:  Makoto Isozaki; Yasushi Kiyono; Yoshikazu Arai; Takashi Kudo; Tetsuya Mori; Rikiya Maruyama; Ken-ichiro Kikuta; Hidehiko Okazawa
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-02-02       Impact factor: 9.236

Review 2.  Human gene therapy and imaging in neurological diseases.

Authors:  Andreas H Jacobs; Alexandra Winkler; Maria G Castro; Pedro Lowenstein
Journal:  Eur J Nucl Med Mol Imaging       Date:  2005-12       Impact factor: 9.236

3.  'Salvaged' stroke ischaemic penumbra shows significant injury: studies with the hypoxia tracer FMISO.

Authors:  Neil J Spratt; Geoffrey A Donnan; Damian D McLeod; David W Howells
Journal:  J Cereb Blood Flow Metab       Date:  2010-09-29       Impact factor: 6.200

4.  Intracranial pressure elevation reduces flow through collateral vessels and the penetrating arterioles they supply. A possible explanation for 'collateral failure' and infarct expansion after ischemic stroke.

Authors:  Daniel J Beard; Damian D McLeod; Caitlin L Logan; Lucy A Murtha; Mohammad S Imtiaz; Dirk F van Helden; Neil J Spratt
Journal:  J Cereb Blood Flow Metab       Date:  2015-02-11       Impact factor: 6.200

Review 5.  Is age a key factor contributing to the disparity between success of neuroprotective strategies in young animals and limited success in elderly stroke patients? Focus on protein homeostasis.

Authors:  Wei Yang; Wulf Paschen
Journal:  J Cereb Blood Flow Metab       Date:  2017-07-28       Impact factor: 6.200

Review 6.  Heterogeneity in the penumbra.

Authors:  Gregory J del Zoppo; Frank R Sharp; Wolf-Dieter Heiss; Gregory W Albers
Journal:  J Cereb Blood Flow Metab       Date:  2011-07-06       Impact factor: 6.200

7.  Impact of retrievable stents on acute ischemic stroke treatment.

Authors:  C Brekenfeld; G Schroth; P Mordasini; U Fischer; M-L Mono; A Weck; M Arnold; M El-Koussy; J Gralla
Journal:  AJNR Am J Neuroradiol       Date:  2011-05-12       Impact factor: 3.825

Review 8.  Imaging of cerebral ischemia: from acute stroke to chronic disorders.

Authors:  May Nour; David S Liebeskind
Journal:  Neurol Clin       Date:  2013-10-23       Impact factor: 3.806

9.  Imaging of hypoxic-ischemic penumbra with (18)F-fluoromisonidazole PET/CT and measurement of related cerebral metabolism in aneurysmal subarachnoid hemorrhage.

Authors:  Asita S Sarrafzadeh; Alexandra Nagel; Marcus Czabanka; Timm Denecke; Peter Vajkoczy; Michail Plotkin
Journal:  J Cereb Blood Flow Metab       Date:  2009-09-23       Impact factor: 6.200

Review 10.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.